Friday Lecture Series
Cancer Biology Lecture
Oncogenic Signaling in the PI3K Pathway
Peter Vogt, Ph.D., professor, department of molecular and experimental medicine,
The Scripps Research Institute
April 29, 2011
3:45 p.m.-5:00 p.m. (Refreshments, 3:15 p.m., Abby Lounge)
Caspary Auditorium
Bader, A. G., S. Kang, and P. K. Vogt. 2006. Cancer-specific mutations in PIK3CA are oncogenic in vivo. Proceedings of the National Academy of Sciences of the United States of America 103, (5): 1475-1479
Bader, A. G., S. Kang, L. Zhao, and P. K. Vogt. 2005. Oncogenic PI3K deregulates transcription and translation. Nature Reviews Cancer 5, (12): 921-929
Vogt, P. K., M. Gymnopoulos, and J. R. Hart. 2009. PI 3-kinase and cancer: Changing accents. Current Opinion in Genetics and Development 19, (1): 12-17
Vogt, P. K., S. Kang, M. -A Elsliger, and M. Gymnopoulos. 2007. Cancer-specific mutations in phosphatidylinositol 3-kinase. Trends in biochemical sciences 32, (7): 342-349
Zhao, L., and P. K. Vogt. 2008. Class I PI3K in oncogenic cellular transformation. Oncogene 27, (41): 5486-5496
April 8, 2011 – Fermi National Accelerator Laboratory physicists